Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry D Hinds

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Trends in Endocrinology and Metabolism: TEM|September 5, 2021
FKBP51 and the molecular chaperoning of metabolismKathryn B Smedlund, Edwin R Sanchez, Terry D Hinds
Trends in Molecular Medicine|February 24, 2023
The physiology of bilirubin: health and disease equilibriumLibor Vitek, Terry D Hinds, David E Stec, et al.
Translational Stroke Research|November 18, 2015
Ginkgo biloba Extract Prevents Female Mice from Ischemic Brain Damage and the Mechanism Is Independent of the HO1/Wnt PathwayJatin Tulsulkar, Bryan Glueck, Terry D Hinds, et al.
Pharmacology Research & Perspectives|December 16, 2014
Analysis of FK506, timcodar (VX-853) and FKBP51 and FKBP52 chaperones in control of glucocorticoid receptor activity and phosphorylationTerry D Hinds, Lance A Stechschulte, Fadel Elkhairi, et al.
Trends in Endocrinology and Metabolism: TEM|February 8, 2018
Bilirubin in the Liver-Gut Signaling AxisAbdul-Rizaq Hamoud, Lauren Weaver, David E Stec, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 2, 2018
Biliverdin reductase and bilirubin in hepatic diseaseLauren Weaver, Abdul-Rizaq Hamoud, David E Stec, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 31, 2015
The glucocorticoid receptor: cause of or cure for obesity?Kezia John, Joseph S Marino, Edwin R Sanchez, et al.
Kidney360|September 21, 2022
Novel Function for Bilirubin as a Metabolic Signaling Molecule: Implications for Kidney DiseasesDavid E Stec, Claudio Tiribelli, Olufunto O Badmus, et al.
Medical Hypotheses|October 4, 2016
Does bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor?Terry D Hinds, Samuel O Adeosun, Abdulhadi A Alamodi, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 7, 2020
Bilirubin as a metabolic hormone: the physiological relevance of low levelsJustin F Creeden, Darren M Gordon, David E Stec, et al.
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Trends in Endocrinology and Metabolism: TEM|September 5, 2021
FKBP51 and the molecular chaperoning of metabolismKathryn B Smedlund, Edwin R Sanchez, Terry D Hinds
Trends in Molecular Medicine|February 24, 2023
The physiology of bilirubin: health and disease equilibriumLibor Vitek, Terry D Hinds, David E Stec, et al.
Translational Stroke Research|November 18, 2015
Ginkgo biloba Extract Prevents Female Mice from Ischemic Brain Damage and the Mechanism Is Independent of the HO1/Wnt PathwayJatin Tulsulkar, Bryan Glueck, Terry D Hinds, et al.
Pharmacology Research & Perspectives|December 16, 2014
Analysis of FK506, timcodar (VX-853) and FKBP51 and FKBP52 chaperones in control of glucocorticoid receptor activity and phosphorylationTerry D Hinds, Lance A Stechschulte, Fadel Elkhairi, et al.
Trends in Endocrinology and Metabolism: TEM|February 8, 2018
Bilirubin in the Liver-Gut Signaling AxisAbdul-Rizaq Hamoud, Lauren Weaver, David E Stec, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 2, 2018
Biliverdin reductase and bilirubin in hepatic diseaseLauren Weaver, Abdul-Rizaq Hamoud, David E Stec, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 31, 2015
The glucocorticoid receptor: cause of or cure for obesity?Kezia John, Joseph S Marino, Edwin R Sanchez, et al.
Kidney360|September 21, 2022
Novel Function for Bilirubin as a Metabolic Signaling Molecule: Implications for Kidney DiseasesDavid E Stec, Claudio Tiribelli, Olufunto O Badmus, et al.
Medical Hypotheses|October 4, 2016
Does bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor?Terry D Hinds, Samuel O Adeosun, Abdulhadi A Alamodi, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 7, 2020
Bilirubin as a metabolic hormone: the physiological relevance of low levelsJustin F Creeden, Darren M Gordon, David E Stec, et al.
Pageof 11